This compound is a deuterium-labeled pyridazine carboxamide derivative, featuring a chloro-substituted pyridazine ring connected to a methoxy-substituted aniline moiety bearing a triazole group. It is primarily encountered as a research reagent or pharmaceutical intermediate.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
pharmaceutical intermediate
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-, methyl ester
pharmaceutical intermediate
Deucravacitinib
pharmaceutical raw material
4,4,4,4-(1,3,6,8-Pyrenetetrayl)tetrakis[benzenamine]
chemical intermediate for research
3,5-Dibromotoluene
Laboratory reagent
2,5-Dichloropyridine
chemical intermediate for research and manufacturing
3,6-dioxabicyclo[3.1.0]hexane-2,4-dione
research compound
6-chloro-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
WMVBKFNYOMTBPE-FIBGUPNXSA-N
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.